Shingles vaccine drastically cuts risk of serious cardiac events
People with heart disease who received a shingles vaccine had nearly half the rate of serious cardiac events a year later compared with those who did not get… read more.
People with heart disease who received a shingles vaccine had nearly half the rate of serious cardiac events a year later compared with those who did not get… read more.
Novartis announced today that Cosentyx (secukinumab) received FDA approval for treating pediatric patients 12 years and older with moderate to severe hidradenitis suppurativa (HS), making it the only IL-17A inhibitor for this population. The… read more.
The first major update to resistance-training guidelines in 17 years delivers one clear message: any amount of resistance training improves strength, muscle size, power and physical function. The… read more.
In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder… read more.
The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has granted a marketing authorisation on on 20 February 2026 to to Insmed Netherlands B.V. for brensocatib (Brinsupri) to… read more.
One in ten emergency patients with visible blood in their urine die within three months of presenting at A&E, new research has found. The WASHOUT study, presented today… read more.
A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal cannabis is… read more.
The Phase III study FIND-CKD, evaluating the efficacy and safety of finerenone (Kerendia) versus placebo when added to standard of care in adult patients with non-diabetic chronic kidney… read more.
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research. The findings are presented today… read more.
A team of University of Mississippi researchers is developing a way to use 3D printed medicated patches to help close persistent sores and ulcers. The researchers in the School… read more.
Eli Lilly and Company announced that access to self-pay pricing on the new Zepbound (tirzepatide) KwikPen for single-patient use will be available at LillyDirect and major pharmacies nationwide,… read more.
Falls are one of the leading causes of injury and hospitalization among older adults, placing significant strain on individuals, families and the health-care system. And new research by… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.